Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.20
(
-0.14%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.35
(
-2.09%
)
Bitcoin
70,325.46
(
-1.29%
)
News Focus
News Focus
Post# of 257261
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

scott2987

Send PM Follow Ignore
Followers 0
Posts 47
Boards Moderated 0
Alias Born 11/04/2003

scott2987

Re: DewDiligence post# 209317

Wednesday, 02/22/2017 1:57:23 PM

Wednesday, February 22, 2017 1:57:23 PM

Post# of 257261
I have been a little surprised that no question came up yesterday or in previous presentation by CFO about whether MNTA was developing their Humira biosimilar to be interchangable and Craig simply referred to it as a high quality biosimilar and interchangable status was never mentioned. Is there a reason they would not talk about that?
Thanks
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now